Criteria
Leader criteria
Sector
Communication Services
80
Consumer Discretionary
292
Consumer Staples
106
Energy
122
Financials
467
Health Care
446
Industrials
477
Information Technology
431
Materials
223
Real Estate
119
Utilities
77
Russell 3000. FTSE Russell does not publish this list, so it is reconstructed here as the 3,000 largest US operating companies by market value. It will not match the published index name for name.
Russell 3000
| Ticker ▲ | Company | Index | Sector | Price | 1wk | 1mo | 1yr | ATR% | RS | Trend | Market cap | P/E | PEG | ROE | P/B | D/E | EPS growth | F-score | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ETRA | Electra Therapeutics, Inc. | Health Care | $8.10 | down 7.0% | down 28.0% | — | 11.5% | — | — | — | — | — | — | — | — | — | — | Unknown | |
| EW | Edwards Lifesciences Corp | Health Care | $92.01 | up 3.3% | up 6.6% | up 10.2% | 2.4% | 59 | 6/8 | $53.4B | 49.8× | — | up 11% | 5.2× | 0.06 | down 26% | 5/9 | Low | |
| EWTX | Edgewise Therapeutics, Inc. | Health Care | $38.90 | down 1.0% | down 4.2% | up 108.4% | 4.9% | 91 | 7/8 | $4.1B | — | — | 0% | 7.9× | — | — | — | Unknown | |
| EXEL | Exelixis, Inc. | Health Care | $69.39 | up 7.5% | up 18.8% | up 78.2% | 2.7% | 93 | 8/8 | $18.2B | 23.3× | 0.40 | up 36% | 8.4× | — | up 23% | 7/9 | Low | |
| EYE | National Vision Holdings, Inc. | Health Care | $16.59 | down 11.1% | up 1.3% | down 36.8% | 5.1% | 7 | 0/8 | $1.3B | 44.5× | — | up 4% | 1.5× | 0.26 | up 41% | — | Moderate | |
| FDMT | 4D Molecular Therapeutics, Inc. | Health Care | $11.90 | up 10.2% | down 16.8% | up 5.1% | 8.1% | 78 | 6/8 | $685.5M | — | — | down 28% | 1.4× | 0.00 | — | — | Low | |
| FENC | Fennec Pharmaceuticals Inc. | Health Care | $10.24 | up 1.6% | down 3.8% | up 22.9% | 5.3% | 81 | 7/8 | $349.8M | — | — | down 27461% | 9.9× | — | — | — | Moderate | |
| FLGT | Fulgent Genetics, Inc. | Health Care | $20.62 | up 2.6% | down 6.4% | down 8.7% | 3.9% | 62 | 3/8 | $640.9M | — | — | down 5% | 0.6× | 0.00 | — | 4/9 | Low | |
| FRNM | Freenome, Inc. | Health Care | $12.48 | down 2.3% | down 20.8% | up 16.6% | 7.9% | 60 | 2/8 | — | — | — | — | — | — | — | — | Elevated | |
| FTH | Faeth Therapeutics, Inc. | Health Care | $18.69 | up 9.4% | down 37.2% | up 97.7% | 12.6% | 77 | 5/8 | $23.6M | — | — | down 74% | 1.3× | — | — | — | Unknown | |
| FTRE | Fortrea Holdings Inc. | Health Care | $21.29 | down 9.9% | up 6.7% | up 112.3% | 6.8% | 92 | 8/8 | $2.0B | — | — | down 103% | 3.5× | 1.86 | — | — | Elevated | |
| GEHC | Ge Healthcare Technologies Inc. | Health Care | $76.57 | up 7.2% | up 17.2% | up 2.2% | 2.7% | 59 | 3/8 | $35.1B | 16.9× | 3.52 | up 22% | 3.4× | 0.91 | up 39% | 5/9 | Moderate | |
| GENB | Generate Biomedicines, Inc. | Health Care | $14.46 | up 16.5% | down 3.7% | — | 7.1% | — | — | — | — | — | — | — | — | — | — | Unknown | |
| GERN | Geron Corp | Health Care | $0.89 | down 20.5% | down 27.6% | down 28.2% | 9.0% | 7 | 0/8 | $569.5M | — | — | down 33% | 2.5× | 0.53 | — | — | Unknown | |
| GH | Guardant Health, Inc. | Health Care | $178.80 | up 5.7% | up 0.2% | up 93.5% | 4.7% | 96 | 8/8 | $23.4B | — | — | — | — | — | — | 4/9 | Elevated | |
| GHRS | Gh Research Plc | Health Care | $20.86 | up 15.4% | down 11.2% | up 66.3% | 5.7% | 56 | 4/8 | — | — | — | — | — | — | — | — | Unknown | |
| GILD | Gilead Sciences, Inc. | Health Care | $170.68 | up 9.4% | up 14.5% | up 46.8% | 2.6% | 87 | 7/8 | $211.8B | 24.9× | 0.01 | up 40% | 9.3× | 0.97 | down 20% | 8/9 | Low | |
| GKOS | Glaukos Corp | Health Care | $237.60 | up 32.8% | up 44.7% | up 170.6% | 4.8% | 98 | 8/8 | $13.7B | — | — | down 26% | 20.8× | — | — | 3/9 | Low | |
| GLUE | Monte Rosa Therapeutics, Inc. | Health Care | $10.76 | down 0.7% | down 9.8% | down 17.3% | 5.7% | 7 | 0/8 | $705.3M | — | — | down 17% | 3.0× | — | — | — | Elevated | |
| GMAB | Genmab A/S | Health Care | $57.06 | up 30.3% | up 59.9% | up 99.0% | 4.3% | 98 | 8/8 | — | — | — | — | — | — | — | — | Unknown | |
| GMED | Globus Medical Inc | Health Care | $78.05 | down 4.1% | up 4.2% | up 28.5% | 2.9% | 39 | 2/8 | — | — | — | up 12% | — | — | down 26% | — | Unknown | |
| GRAL | Grail, Inc. | Health Care | $143.43 | up 8.2% | up 2.4% | up 57.4% | 7.4% | 98 | 8/8 | $5.8B | — | — | down 16% | 2.2× | — | — | — | Elevated | |
| HAE | Haemonetics Corp | Health Care | $119.65 | up 1.0% | up 13.6% | up 139.3% | 2.7% | 97 | 8/8 | $5.4B | 55642.7× | — | 0% | 6.8× | 1.53 | up 3% | 6/9 | Low | |
| HALO | Halozyme Therapeutics, Inc. | Health Care | $130.91 | up 4.2% | up 18.6% | up 102.6% | 2.5% | 97 | 8/8 | $15.4B | 48.7× | — | up 154% | 315.9× | 43.89 | up 43% | 5/9 | Low | |
| HCA | Hca Healthcare, Inc. | Health Care | $473.19 | up 0.9% | up 10.9% | up 1.9% | 3.1% | 59 | 4/8 | $106.3B | 15.7× | 0.54 | — | — | — | up 4% | — | Elevated |